CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis

Dongwei Dou,Xiaoyang Ren,Mingli Han,Xiaodong Xu,Xin Ge,Yuanting Gu,Xinxing Wang,Song Zhao
DOI: https://doi.org/10.1186/s12935-020-01547-7
IF: 6.429
2020-09-14
Cancer Cell International
Abstract:Abstract Background Triple-negative breast cancer (TNBC) is a clinically aggressive subtype of breast cancer with a bad prognosis. Chemotherapy is still the standard of care for TNBC treatment. Circular RNAs (CircRNAs) have been recently discovered to be closely involved in the initiation and development of human cancers. Herein, we focus our attention on the functions and underlying mechanisms of circUBE2D2 in TNBC progression and chemoresistance. Methods The expression of circUBE2D2, miR-512-3p, and cell division cycle associated 3 (CDCA3) mRNA were determined by qRT-PCR. CCK-8, colony formation, transwell and flow cytometry assays were performed to detect cell proliferation, migration, invasion and apoptosis. Western blot assay was utilized to measure the protein level of CDCA3. RNA pull-down, luciferase reporter and RIP experiments were employed to examine the possible regulatory mechanism of circUBE2D2. Results CircUBE2D2 expression was elevated in TNBC tissues and cells. TNBC patients with high circUBE2D2 expression are inclined to present advanced TNM stage, lymph node metastasis and adverse prognosis. Knockdown of circUBE2D2 repressed cell proliferation, migration and invasion in vitro, and impeded tumor growth in vivo. Moreover, silencing of circUBE2D2 reduced doxorubicin resistance of TNBC cells. In-depth mechanism analysis revealed that circUBE2D2 served as a miRNA sponge to protect CDCA3 from the attack of miR-512-3p. Additionally, the tumor-suppressive effect induced by circUBE2D2 depletion was greatly impaired upon miR512-3p down-regulation or CDCA3 overexpression. Also, depletion of circUBE2D2 decreased the resistance to doxorubicin through regulating miR-512-3p/CDCA3 axis. Conclusion CircUBE2D2 promoted TNBC progression and doxorubicin resistance through acting as a sponge of miR-512-3p to up-regulate CDCA3 expression. Targeting circUBE2D2 combine with doxorubicin might be exploited as a novel therapy for TNBC.
oncology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the function of circular RNA circUBE2D2 in triple - negative breast cancer (TNBC) and its mechanism of action in tumor progression and chemoresistance. Specifically: 1. **Explore the expression of circUBE2D2 in TNBC**: The study found that the expression of circUBE2D2 was significantly up - regulated in TNBC tissues and cells, and high expression was associated with advanced TNM staging, lymph node metastasis and poor prognosis. 2. **Analyze the impact of circUBE2D2 on the proliferation, migration and invasion of TNBC cells**: By knocking down the expression of circUBE2D2, the researchers observed that the proliferation, migration and invasion abilities of TNBC cells were inhibited, and in - vivo experiments also confirmed that knocking down circUBE2D2 could inhibit tumor growth. 3. **Study the impact of circUBE2D2 on the chemoresistance of TNBC cells**: The study found that knocking down circUBE2D2 could reduce the resistance of TNBC cells to doxorubicin and enhance drug - induced apoptosis. 4. **Reveal the mechanism of action of circUBE2D2**: Further mechanistic studies have shown that circUBE2D2 promotes the progression of TNBC and chemoresistance by acting as a molecular sponge for miR - 512 - 3p and relieving the inhibitory effect of miR - 512 - 3p on CDCA3. In summary, this paper aims to reveal the oncogenic role of circUBE2D2 in TNBC and its mechanism of affecting tumor progression and chemoresistance by regulating the miR - 512 - 3p/CDCA3 axis, providing new targets and strategies for the treatment of TNBC.